Regulation of BRCA1 expression and its relationship to sporadic breast cancer

Breast Cancer Research

Volumn 5, Issue 1, 2003, Pages 45-52

  Mueller, Christopher R ^a   Roskelley, Calvin D ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

BRCA1; Breast cancer; Development; Sporadic; Transcription

Indexed keywords

BRCA1 PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER GROWTH; CANCER PREVENTION; CORRELATION FUNCTION; FAMILIAL CANCER; GENE MUTATION; GERM LINE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS);

EID: 0038743059     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr557     Document Type: Review

References (78)

1. Casey G: The BRCA1 and BRCA2 breast cancer genes. Curr Opin Oncol 1997, 9:88-93.
2. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
3. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Goldgar DE, et al: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet 1996, 12:333-337.
4. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002, 108:171-182.
5. Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M: Direct DNA binding by Brca1. Proc Natl Acad Sci USA 2001, 98:6086-6091.
6. Yarden RI, Pardo-Reoyo S, Sgagias M, Cowan KH, Brody LC: BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 2002, 30:285-289.
7. Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R: BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 2001, 155:911-921.
8. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX: Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999, 22: 37-43.
9. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al.: BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994, 266:120-122.
10. Papa S, Seripa D, Merla G, Gravina C, Giai M, Sismondi P, Rinaldi M, Serra A, Saglio G, Fazio VM: Identification of a possible somatic BRCA1 mutation affecting translation efficiency in an early-onset sporadic breast cancer patient. J Natl Cancer Inst 1998, 90:1011-1012.
11. van der LM, Cleton-Jansen AM, van Eijk R, Morreau H, van Vliet M, Kuipers-Dijkshoorn N, Olah E, Comelisse CJ, Devilee P: A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1. Genes Chromosomes Cancer 2000, 27:295-302.
12. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995, 9:444-450.
13. Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, Coombes RC, Ali S: An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer 1998, 79:334-342.
14. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 1999, 21:236-240.
15. Jarvis EM, Kirk JA, Clarke CL: Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet Cytogenet 1998, 101:109-115.
16. Lee WY, Jin YT, Chang TW, Lin PW, Su IJ: Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology 1999, 34:106-112.
17. Seery LT, Knowlden JM, Gee JM, Robertson JF, Kenny FS, Ellis IO, Nicholson RI: BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer 1999, 84: 258-262.
18. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, Okuyama T, Shimada T, Kodoma H, Noguchi S, Gazdar AF, Yamaoka Y, Takahashi R: Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res 1999, 5:1249-1261.
19. Yang Q, Sakurai T, Mori I, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, Tamaki T, Umemura T, Kakudo K: Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer 2001, 92:54-60.
20. Russell PA, Pharoah PD, De Foy K, Ramus SJ, Symmonds I, Wilson A, Scott I, Ponder BA, Gayther SA: Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int J Cancer 2000, 87:317-321.
21. Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB, Neckers LM: Regulation of BRCA1 by protein degradation. Oncogene 1999, 18:6460-6468.
22. Rio PG, Pernin D, Bay JO, Albusson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ, Bignon YJ: Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int J Oncol 1998, 13:849-853.
23. Rio PG, Maurizis JC, Peffault DL, Bignon YJ, Bernard-Gallon DJ: Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer 1999, 80:823-826.
24. Ozcelik H, To MD, Couture J, Bull SB, Andrulis IL: Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer 1998, 77:1-6.
25. Herman JG, Baylin SB: Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 2000, 249:35-54.
26. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK: CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998, 16:1161-1169.
27. Magdinier F, Ribieras S, Lenoir GM, Frappart L, Dante R: Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 1998, 17:3169-3176.
28. Dobrovic A, Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997, 57:3347-3350.
29. Rice JC, Massey-Brown KS, Futscher BW: Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 1998, 17:1807-1812.
30. Magdinier F, Billard LM, Wittmann G, Frappart L, Benchaib M, Lenoir GM, Guerin JF, Dante R: Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J 2000, 14:1585-1594.
31. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW: Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 2000, 21:1761-1765.
32. Rice JC, Futscher BW: Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res 2000, 28:3233-3239.
33. Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 1999, 18:1957-1965.
34. Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D, Solomon E: The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q2l. Oncogene 1996, 12:2507-2513.
35. Xu CF, Brown MA, Nicolai H, Chambers JA, Griffiths BL, Solomon E: Isolation and characterisation of the NBR2 gene which lies head to head with the human BRCA1 gene. Hum Mol Genet 1997, 6:1057-1062.
36. Chambers JA, Solomon E: Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene. Genomics 1996, 38:305-313.
37. Xu CF, Brown MA, Chambers JA, Griffiths B, Nicolai H, Solomon E: Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet 1995, 4:2259-2264.
38. Xu C-F, Chambers JA, Solomon E: Complex regulation of the BRCA1 gene. J Biol Chem 1997, 272:20994-20997.
39. Thakur S, Croce CM: Positive regulation of the BRCA1 promoter. J Biol Chem 1999, 274:8837-8843.
40. Suen TC, Goss PE: Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoter. J Biol Chem 1999, 274:31297-31304.
41. Dimitrov SD, Matouskova E, Forejt J: Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells. Folia Biol (Praha) 2001, 47:120-127.
42. Gudas JM, Li T, Nguyen H, Jensen D, Rauscher FJ, Cowan KH: Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 1996, 7:717-723.
43. Spillman MA, Bowcock AM: BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 1996, 13:1639-1645.
44. Romagnolo D, Annab LA, Thompson TE, Risinger JI, Terry LA, Barrett JC, Afshari CA: Estrogen upregulation of BRCA1 expression with no effect on localization. Mol Carcinog 1998, 22:102-109.
45. Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP, Wiseman RW, Futreal PA, Iglehart JD: BRCA1 expression is not directly responsive to estrogen. Oncogene 1997, 14:115-121.
46. Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC, Johnson DG: Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem 2000, 275:4532-4536.
47. MacLachlan TK, Dash B, Dicker DT, El-Deiry W: Repression of BRCA1 through a feedback loop involving p53. J Biol Chem 2000, 275:2777-2785.
48. Suen TC, Goss PE: Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. Oncogene 2001, 20:440-450.
49. DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI: Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene 2001, 20:5331-5340.
50. Atlas E, Stramwasser M, Mueller CR: A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene 2001, 20:7110-7114.
51. Atlas E, Stramwasser M, Whiskin K, Mueller CR: GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter. Oncogene 2000, 19:1933-1940.
52. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P, Welch PJ, Welte K, King MC, Barber JR, Wong-Staal F: Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci USA 2001, 98:130-135.
53. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA, King MC: BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 2002, 99:7560-7565.
54. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL, Chodosh LA: The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995, 11:17-26.
55. Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, Leder P: Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 1995, 9:2712-2722.
56. Rajan JV, Wang M, Marquis ST, Chodosh LA: Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 1996, 93:13078-13083.
57. Blackshear PE, Goldsworthy SM, Foley JF, McAllister KA, Bennett LM, Collins NK, Bunch DO, Brown P, Wiseman RW, Davis BJ: Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene 1998, 16:61-68.
58. Rajan JV, Marquis ST, Gardner HP, Chodosh LA: Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 1997, 184:385-401.
59. Hennighausen L, Robinson GW: Think globally, act locally: the making of a mouse mammary gland. Genes Dev 1998, 12: 449-455.
60. Gudas JM, Nguyen H, Li T, Cowan KH: Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 1995, 55:4561-4565.
61. Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ, Bernard-Gallon DJ: Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem Biophys Res Commun 1999, 258:284-291.
62. Laud K, Hornez L, Gourdou I, Belair L, Arnold A, Peyrat JP, Djiane J: Expression of BRCA1 gene in ewe mammary epithelial cells during pregnancy: regulation by growth hormone and steroid hormones. Eur J Endocrinol 2001, 145:763-770.
63. Wiseman BS, Werb Z: Stromal effects on mammary gland development and breast cancer. Science 2002, 296:1046-1049.
64. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W: Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 1995, 131:215-226.
65. Fromm L, Burden SJ: Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABP-beta. Genes Dev 1998, 12:3074-3083.
66. Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz AP, Roskelley C, Bissell MJ: Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol 1995, 129:591-603.
67. Streuli CH, Edwards GM, Delcommenne M, Whitelaw CB, Burdon TG, Schindler C, Watson CJ: Stat5 as a target for regulation by extracellular matrix. J Biol Chem 1995, 270:21639-21644.
68. Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992, 118:1271-1282.
69. Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA, Khokha R: Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 2001, 108:831-841.
70. O'Connell FC, Martin F: Laminin-rich extracellular matrix association with mammary epithelial cells suppresses brca1 expression. Cell Death Differ 2000, 7:360-367.
71. Myers CA, Schmidhauser C, Mellentin-Michelotti J, Fragoso G, Roskelley CD, Casperson G, Mossi R, Pujuguet P, Hager G, Bissell MJ: Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol Cell Biol 1998, 18:2184-2195,
72. Troyer KL, Lee DC: Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 2001, 6:7-21.
73. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z: Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693.
74. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z: The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-146.
75. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245.
76. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ: Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 1998, 95:14821-14826.
77. Desprez PY, Hara E, Bissell MJ, Campisi J: Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol 1995, 15:3398-3404.
78. Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J, Desprez PY: Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem 2001, 276:39213-39219.